Invesco Ltd [NYSE: IVZ] stock went on an upward path that rose over 0.51% on Thursday, amounting to a one-week price decrease of less than -2.95%.
Over the last 12 months, IVZ stock rose by 29.49%. The one-year Invesco Ltd stock forecast points to a potential upside of 7.56. The average equity rating for IVZ stock is currently 2.84, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $7.97 billion, with 449.50 million shares outstanding and 441.87 million shares in the current float. Compared to the average trading volume of 3.57M shares, IVZ stock reached a trading volume of 3482670 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Invesco Ltd [IVZ]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IVZ shares is $19.19 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IVZ stock is a recommendation set at 2.84. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Invesco Ltd shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on September 12, 2024. While these analysts kept the previous recommendation, Barclays raised their target price to Equal Weight. The new note on the price target was released on August 27, 2024, representing the official price target for Invesco Ltd stock. Previously, the target price had yet another raise to $21, while TD Cowen analysts kept a Outperform rating on IVZ stock. On December 14, 2023, analysts increased their price target for IVZ shares from 15.50 to 20.
The Average True Range (ATR) for Invesco Ltd is set at 0.49, with the Price to Sales ratio for IVZ stock in the period of the last 12 months amounting to 1.35. The Price to Book ratio for the last quarter was 0.74, with the Price to Cash per share for the same quarter was set at 3.65. Price to Free Cash Flow for IVZ in the course of the last twelve months was 6.22.
IVZ Stock Performance Analysis:
Invesco Ltd [IVZ] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.95. With this latest performance, IVZ shares dropped by -2.37% in over the last four-week period, additionally plugging by 10.25% over the last 6 months – not to mention a rise of 29.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IVZ stock in for the last two-week period is set at 49.41, with the RSI for the last a single of trading hit 47.26, and the three-weeks RSI is set at 50.90 for Invesco Ltd [IVZ]. The present Moving Average for the last 50 days of trading for this stock 17.45, while it was recorded at 17.89 for the last single week of trading, and 16.18 for the last 200 days.
IVZ Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IVZ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Invesco Ltd go to 11.60%.
Invesco Ltd [IVZ] Institutonal Ownership Details
There are presently around $89.05%, or 90.55%% of IVZ stock, in the hands of institutional investors. The top three institutional holders of IVZ stocks are: BLACKROCK INC. with ownership of 54.21 million shares, which is approximately 11.8763%. VANGUARD GROUP INC, holding 49.88 million shares of the stock with an approximate value of $$746.18 million in IVZ stocks shares; and VANGUARD GROUP INC, currently with $$407.27 million in IVZ stock with ownership which is approximately 5.9642%.
